SCHEMBL30691149

SCHEMBL30691149

N[C@H]1CC=CC[C@@H]1c1sc2c(NCc3ccccc3)cc(Cl)nc2c1Cl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 1/20 0.33
▸ KCNN1 Q92952 1/20 0.33
▸ KCNN2 Q9H2S1 1/20 0.33
▸ KCNN3 Q9UGI6 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ ADORA3 P0DMS8 2/20 0.32
▸ ADORA2A P29274 2/20 0.32
▸ ADORA2B P29275 2/20 0.32
▸ ADORA1 P30542 2/20 0.32
▸ LMNA P02545 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ CISD1 Q9NZ45 1/20 0.31
▸ PKM P14618 1/20 0.31
▸ BRD4 O60885 1/20 0.31
▸ KAT2B Q92831 1/20 0.31
▸ BRD9 Q9H8M2 1/20 0.31
▸ EGFR P00533 1/20 0.30
▸ BACE1 P56817 1/20 0.30
▸ CD38 P28907 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30691524 1.00 DPP4 (0.33) DPP4KCNN1KCNN2KCNN3SMN1; SMN2
SCHEMBL30691382 0.91 MEN1 (0.32) L3MBTL1
SCHEMBL30691530 0.91 MEN1 (0.32) L3MBTL1
SCHEMBL30691648 0.91 ADORA3 (0.36) DPP4KCNN1KCNN2KCNN3SMN1; SMN2
SCHEMBL30691573 0.90 DPP4 (0.32) DPP4KCNN1KCNN2KCNN3SMN1; SMN2
SCHEMBL30691760 0.90 DPP4 (0.32) DPP4KCNN1KCNN2KCNN3SMN1; SMN2
SCHEMBL30691533 0.90 DPP4 (0.32) DPP4KCNN1KCNN2KCNN3SMN1; SMN2
SCHEMBL30691238 0.90 DPP4 (0.32) DPP4KCNN1KCNN2KCNN3SMN1; SMN2
SCHEMBL31570076 0.86 KCNN1 (0.33) DPP4KCNN1KCNN2KCNN3SMN1; SMN2
SCHEMBL31570049 0.86 CDK1 (0.34) KCNN1KCNN2KCNN3SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119997954-A Compounds for the treatment of spinocerebellar ataxia type 3 PTC医疗公司 2025-05-13 — — CN claimed
EP-4543444-A1 COMPOUNDS FOR TREATING SPINOCEREBELLAR ATAXIA TYPE 3 PTC Therapeutics, Inc. (US) 2025-04-30 — — EP claimed
WO-2023250316-A1 COMPOUNDS FOR TREATING SPINOCEREBELLAR ATAXIA TYPE 3 PTC THERAPEUTICS, INC. (US) 2023-12-28 — — WO claimed
Send feedback